Bioprojet

Company snapshot

Bioprojet is a pharmaceutical laboratory committed to science and health. In the last 40 years, we’ve brought forward breakthrough medicines, helping patients struggling with challenging diseases. With passion and integrity, we follow the path set by Jeanne-Marie Lecomte and Jean-Charles Schwartz, founders of Bioprojet. At Bioprojet, we grow to keep honoring our motto : Passion for Research. Resea

• 11 active pipeline program(s) linked via ClinicalTrials.gov.
• 9 US patent(s) indexed to this assignee profile.
• 11 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Bioprojet. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Bioprojet.

1. Jun 8, 2026 Clinical update

   P23-01 — Phase 1

2. Jun 8, 2026 Clinical update

   P25-01 — Phase 1

3. Jun 8, 2026 Clinical update

   P24-06 — Phase 1

4. Jun 8, 2026 Clinical update

   P24-03 — Phase 1

5. Jun 8, 2026 Clinical update

   P22-03 — Phase 1

View all clinical trial activity →

• What is Bioprojet?

  Bioprojet Pharma is a pharma organization headquartered in PARIS, FR. Primary therapeutic focus areas include Eosinophilic esophagitis, Narcolepsy, narcolepsy with cataplexy, Narcolepsy, Narcolepsy, Narcolepsy with cataplexy, Essential tremor. NovaPharmaNews links 11 clinical pro

• Is Bioprojet publicly traded?

  Bioprojet appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Bioprojet develop or market?

  We link 19 drug profile(s) where Bioprojet is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/bioprojet-pharma#company-drugs.

• What are the latest developments for Bioprojet?

  In the last 12 months our linked public records show 11 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Bioprojet focus on?

  Bioprojet focuses on Eosinophilic esophagitis, Narcolepsy, narcolepsy with cataplexy, Narcolepsy based on our analysis of their pipeline programs and drug development activities.